NIBEC Co., Ltd. (KOSDAQ:138610)

South Korea · Delayed Price · Currency is KRW

32,050

+1,000 (3.22%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceuticals	24.55B	15.70B	21.67B	-	-
Pharmaceuticals Growth	56.33%	-27.53%	-	-	-
Total	24.55B	15.70B	21.67B	-	-
Total Growth	56.33%	-27.53%	-	-	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
South Korea	4.44B	3.89B	3.42B	-	-
South Korea Growth	14.33%	13.63%	-	-	-
Foreign	20.11B	11.82B	18.25B	-	-
Foreign Growth	70.14%	-35.25%	-	-	-
Total	24.55B	15.70B	21.67B	-	-
Total Growth	56.33%	-27.53%	-	-	-

Source: S&P Global Market Intelligence.